aTyr Pharma, Inc. (ATYR) Stock

Healthcare · Biotechnology · Member of Other US Stocks

aTyr Pharma, Inc. (ATYR) closed at USD 0.18 on 2026-10-14, a change of -80.9 % over the past year, with a market capitalization of USD 18.03M.

aTyr Pharma, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

aTyr Pharma, Inc. key figures

Previous close

USD 0.18 (2026-10-14)

1-year change

-80.9 %

Market cap

USD 18.03M

Enterprise value

USD -28.28M

P/E ratio (trailing)

-0.30

P/E ratio (forward)

-0.39

EPS (trailing)

-0.62

EPS (forward)

-0.47

PEG ratio

n/a

Price to book

0.37

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.72

Employees

58

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About aTyr Pharma, Inc.

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment of other ILDs, such as chronic hypersensitivity pneumonitis (CHP) and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for aTyr Pharma, Inc. and compare it with other stocks.